The Poster Hall at #NLASessions was absolutely electric! A record number of abstracts, incredible research, and so much passion on display. Congratulations to every single presenter who shared their work this weekend!👏
In the midst of all the action, Social Ambassador Dr. Navid Radfar interviewed Dr. Andrew Cyr about one of the hottest topics of the meeting: Lp(a). The future of lipidology is in outstanding hands!
@navid_radfar
#NLASessions #Lipidology #AbstractPresentations #CardiometabolicHealth #PreventiveCardiology
Day 3: Rewriting the Rules for Primary Prevention
Decades of data are clear: the lower the LDL-C, the better. Time to rethink the reactive approach and start lowering sooner. VESALIUS-CV is the first major PCSK9i outcomes trial to push into the pre-event space.
@nationallipid
Where PREVENT falls short: it doesn’t incorporate Lp(a), family history, pregnancy complications, genetic risk, or social determinants of health. BMI alone can’t separate muscle from metabolic risk. Imaging helps fill those blind spots by showing actual plaque.
Excellent session by Dr. @DineshKalra at NLA/EAS joint session on augmenting prevention with imaging. Risk scores like PREVENT predict from surrogates, while imaging detects disease itself — adding real precision for patients these calculators underestimate. 🫀
@nationallipid
Great to hear incoming NLA President @DineshKalra address a clear vision for equitable lipid care for underserved patients through partnership with industry. A mission that hits home with our Lp(a) screening initiative in NJ.
#NLASessions2026@nationallipid
Excited to share that I've been selected as a 2026 #NLASessions Media Ambassador! I'll be sharing live coverage, key clinical takeaways, and behind-the-scenes moments from the NLA Scientific Sessions in Chicago this June. Stay tuned! @nationallipid
Introducing your 2026 #NLASessions Media Ambassador Team!🌟🤳
This incredible group will be bringing all the action straight to your screens — from hot-topic presentations and clinical insights to behind-the-scenes moments and everything in between. Make sure you're following them to experience #NLASessions live from Chicago!
@CarlosVergaraMD@BinayMd@frankq1368@navid_radfar
Share YOUR own excitement using our Social Media Toolkit, featuring ready-to-post graphics and captions made just for you.
🔗 https://t.co/AOXczRJFWk
#Lipidology #CardiometabolicHealth #PreventiveCardiology #SocialMediaAmbassador
The Spring/Summer 2026 issue of Pulse Magazine is here! https://t.co/Hq894C7Wm9
Discover inspiring stories from NJMS students, faculty, and alumni—highlighting innovation, community engagement, research, and more. @rutgershealth
Still buzzing after an incredible #ACC26 ⚜️🎷
Grateful for the opportunity to connect with so many great people, exchange ideas, and contribute to the conversation around prevention and precision cardiology 🫀
@ACCinTouch@RutgersCardio@RutgersIMRes#Lpa#CardioTwitter
Do you know your Lp(a) level?
1 in 5 people have high Lp(a), an inherited risk factor for atherosclerosis, yet less than 5% have been screened.
We've made screening easy. Request your free kit today: https://t.co/AG0QFQS0i3
#LpaAwarenessDay#KnowLpa
🙌 Today the 2026 ACC/AHA Guideline on the Management of Dyslipidemia has been released.
📍Key updates shaping contemporary lipid management:
1️⃣ Lp(a) measurement is now recommended at least once in all adults for ASCVD risk assessment.
2️⃣ PREVENT equations replace the Pooled Cohort Equations for estimating 10-year and 30-year ASCVD risk.
3️⃣ LDL-C and non-HDL-C treatment goals return as central therapeutic targets alongside percentage LDL reduction.
4️⃣ Earlier intervention is emphasized to reduce lifelong exposure to atherogenic lipoproteins.
5️⃣ Broader integration of ApoB, CAC scoring, and modern lipid-lowering therapies to refine risk stratification and treatment.
👆 An important step forward in translating decades of lipid research into clinical practice and cardiovascular prevention.
🔓 Open Access
🔗 https://t.co/YS3wivUw6W
@nationallipid@society_eas
Happening tomorrow!⌛
Join us tomorrow @ 12–1 PM ET for a live webinar on Promoting Lipoprotein(a) Awareness and Testing for Risk Identification Through Outreach and Teaching, led by @navid_radfar.
Gain practical strategies you can apply in your practice right away. Secure your spot: https://t.co/eEqR3KDDY0
Our first Practical Pearl of the year is coming up!🩺
Join us Thursday, Feb. 12 (12–1 PM ET) for a live webinar on Promoting Lipoprotein(a) Awareness and Testing for Risk Identification Through Outreach and Teaching, led by @navid_radfar.
Gain practical strategies you can apply in your practice right away. Register now: https://t.co/eEqR3KDDY0